BKNG vs KPTI · P/E 36, rev $7.35B vs rev $68.5M
Booking Holdings Inc (BKNG) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
BKNG currently screens at market cap $186.03B and trailing P/E 35.6. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the BKNG and KPTI stock pages for the full models.
Not investment advice.